Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03111459 · ClinicalTrials.gov registry record · NA
Repair of Thoracoabdominal Aortic Aneurysms
A NA study of Thoracoabdominal Aneurysm, sponsored by The Christ Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 15
- Enrollment target
- 1
- Study location
NCT03111459: Recruiting NA study of Thoracoabdominal Aneurysm, sponsored by The Christ Hospital.
NCT03111459 is a NA study of Thoracoabdominal Aneurysm that is actively recruiting participants, run by The Christ Hospital. The registered enrollment target is 15 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03111459, a NA study of Thoracoabdominal Aneurysm, is actively recruiting participants, sponsored by The Christ Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary objective of the clinical investigation is to assess the use of the Medtronic Valiant Thoracoabdominal Stent Graft System to repair thoracoabdominal aortic aneurysms in patients having appropriate anatomy. The primary intent of the study is to assess safety and preliminary effectiveness of the device. Additionally, the study will assess technical success and treatment success at each follow-up interval.
Primary Outcome
major adverse events include death, bowel ischemia, myocardial infarction, paraplegia, renal failure, respiratory failure, and stroke.
Conditions Studied
Interventions
- DEVICE Medtronic Valiant Thoracoabdominal Stent Graft System
Study Locations (1)
Ohio
- The Christ Hospital - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2017-08-01 |
| Est. Completion | 2029-05 |
| Phase | NA |
What NCT03111459 shows while recruiting
NCT03111459 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Thoracoabdominal Aneurysm appearing as the primary indexed condition, and to 1 intervention - of which Medtronic Valiant Thoracoabdominal Stent Graft System is the first listed.
NCT03111459 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT03111459 about?
NCT03111459 is a clinical study titled "Repair of Thoracoabdominal Aortic Aneurysms". The primary objective of the clinical investigation is to assess the use of the Medtronic Valiant Thoracoabdominal Stent Graft System to repair thoracoabdominal aortic aneurysms in patients having appropriate anatomy. The primary intent of the study is to assess safety and preliminary effectiveness ...
What is the current status of trial NCT03111459?
This trial is currently recruiting. It is a NA study. The enrollment target is 15 participants. The study started on 2017-08-01. Estimated completion is 2029-05.
What conditions does trial NCT03111459 study?
This clinical trial studies the following conditions: Thoracoabdominal Aneurysm.
What interventions are being tested in trial NCT03111459?
The interventions under investigation include: Medtronic Valiant Thoracoabdominal Stent Graft System (DEVICE).
Who is sponsoring clinical trial NCT03111459?
This trial is sponsored by The Christ Hospital, which has 13 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03111459 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03111459's enrollment target sits among peer trials
15 1881st of 2000 higher than 92 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI